Legacy Capital Wealth Partners’s Zimmer Biomet ZBH Stock Holding History

Legacy Capital Wealth Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$553K	Sell	6,425 -12	-0.2%	-$1.05K	0.11%	183
2026 Q1	$582K	Buy	6,437 +2,363	+58%	+$217K	0.12%	179
2025 Q4	$366K	Sell	4,074 -1,013	-20%	-$96.1K	0.08%	261
2025 Q3	$501K	Sell	5,087 -50	-1%	-$4.96K	0.11%	203
2025 Q2	$469K	Sell	5,137 -157	-3%	-$15.2K	0.11%	209
2025 Q1	$599K	Buy	5,294 +976	+23%	+$104K	0.15%	149
2024 Q4	$456K	Buy	+4,318	New	+$463K	0.11%	197
2021 Q1	–	Sell	-3,363	Closed	-$504K	–	106
2020 Q4	$504K	Buy	+3,363	New	+$475K	0.22%	45

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Legacy Capital Wealth Partners's ZBH Position: Q2 2026 in Review

Legacy Capital Wealth Partners reduced its Zimmer Biomet (ZBH) stake by 0.19% in Q2 2026, selling an estimated $1.05K and leaving 6,425 shares worth $553K. The position accounts for 0.11% of the portfolio, ranked #183.

Legacy Capital Wealth Partners first reported a position in ZBH in Q4 2020 and has held it in 8 quarters since. The position peaked at $599K in Q1 2025. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Legacy Capital Wealth Partners held 6,425 shares of Zimmer Biomet worth $553K as of Q2 2026.
Legacy Capital Wealth Partners sold 12 Zimmer Biomet shares in Q2 2026, an estimated $1.05K.
Zimmer Biomet made up 0.11% of Legacy Capital Wealth Partners's portfolio in Q2 2026, its #183 holding.
Legacy Capital Wealth Partners first reported a position in Zimmer Biomet in Q4 2020 and has held it in 8 quarters since.
Legacy Capital Wealth Partners's Zimmer Biomet position peaked at $599K in Q1 2025.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Legacy Capital Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.